| Literature DB >> 29269581 |
Myrofora Goutaki1,2, Florian S Halbeisen1, Ben D Spycher1, Elisabeth Maurer1, Fabiën Belle1, Israel Amirav, Laura Behan3,4, Mieke Boon5, Siobhan Carr6, Carmen Casaulta, Annick Clement, Suzanne Crowley7, Sharon Dell8, Thomas Ferkol9, Eric G Haarman10, Bulent Karadag11, Michael Knowles12, Cordula Koerner-Rettberg13, Margaret W Leigh14, Michael R Loebinger15, Henryk Mazurek16, Lucy Morgan17, Kim G Nielsen18, Maria Phillipsen18, Scott D Sagel19, Francesca Santamaria20, Nicolaus Schwerk21, Panayiotis Yiallouros22, Jane S Lucas3, Claudia E Kuehni23.
Abstract
Chronic respiratory disease can affect growth and nutrition, which can influence lung function. We investigated height, body mass index (BMI), and lung function in patients with primary ciliary dyskinesia (PCD).In this study, based on the international PCD (iPCD) Cohort, we calculated z-scores for height and BMI using World Health Organization (WHO) and national growth references, and assessed associations with age, sex, country, diagnostic certainty, age at diagnosis, organ laterality and lung function in multilevel regression models that accounted for repeated measurements.We analysed 6402 measurements from 1609 iPCD Cohort patients. Height was reduced compared to WHO (z-score -0.12, 95% CI -0.17 to -0.06) and national references (z-score -0.27, 95% CI -0.33 to -0.21) in male and female patients in all age groups, with variation between countries. Height and BMI were higher in patients diagnosed earlier in life (p=0.026 and p<0.001, respectively) and closely associated with forced expiratory volume in 1 s and forced vital capacity z-scores (p<0.001).Our study indicates that both growth and nutrition are affected adversely in PCD patients from early life and are both strongly associated with lung function. If supported by longitudinal studies, these findings suggest that early diagnosis with multidisciplinary management and nutritional advice could improve growth and delay disease progression and lung function impairment in PCD.Entities:
Mesh:
Year: 2017 PMID: 29269581 DOI: 10.1183/13993003.01659-2017
Source DB: PubMed Journal: Eur Respir J ISSN: 0903-1936 Impact factor: 16.671